17 results
8-K
EX-1.1
OPTN
OptiNose Inc
23 Nov 22
Optinose Announces Proposed Public Offering of Common Stock and Warrants
4:09pm
Prospectus or the Prospectus.
(xxxiii) Anti-Corruption Laws. None of the Company, any of its subsidiaries or any of their respective affiliates … , or committed an offence under the Bribery Act of 2010 of the United Kingdom, or any other applicable non-U.S. anti-bribery or anti-corruption laws; or (iv
8-K
EX-10.1
OPTN
OptiNose Inc
21 Nov 22
Entry into a Material Definitive Agreement
6:16am
Interests in the Collateral.
6.20 Business Locations.
6.21 Sanctions Concerns; Anti-Corruption Laws; PATRIOT Act.
6.22 Limited Offering of Notes.
6.23 … Contracts.
7.16 Deposit Accounts.
7.17 Products and Required Permits.
7.18 Consent of Licensors.
7.19 Anti-Corruption Laws; Anti-Money Laundering
8-K
EX-1.1
OPTN
OptiNose Inc
18 Nov 21
Optinose Announces Proposed Public Offering of Common Stock
12:20pm
law or of the character required to be disclosed in the Registration Statement, the Time of Sale Prospectus or the Prospectus.
i. Anti-Corruption Laws … , or any
other applicable non-U.S. anti-bribery or anti-corruption laws; or (iv) made, offered, agreed, requested or taken an act in furtherance of any
8-K
EX-1.1
g9fwx3s7
18 Aug 20
Optinose Announces Pricing of Public Offering of Common Stock
12:00am
8-K
EX-1.1
1bgo33crwxowmv439
21 Nov 19
Optinose Announces Proposed Public Offering of Common Stock
5:11pm
8-K
EX-10.1
lbzh54n3 lx
12 Sep 19
Announces $150 Million Debt Financing from Pharmakon
4:04pm
10-K
EX-10.19
kqbp3z
13 Mar 18
Annual report
12:00am
10-K
yhyx6710hevtfi8wph
13 Mar 18
Annual report
12:00am
424B4
br1t 6h7frh
13 Oct 17
Prospectus supplement with pricing info
12:00am
- Prev
- 1
- Next